GB201518002D0 - Ketamine for the treatment of somatoform pain disorder - Google Patents
Ketamine for the treatment of somatoform pain disorderInfo
- Publication number
- GB201518002D0 GB201518002D0 GBGB1518002.9A GB201518002A GB201518002D0 GB 201518002 D0 GB201518002 D0 GB 201518002D0 GB 201518002 A GB201518002 A GB 201518002A GB 201518002 D0 GB201518002 D0 GB 201518002D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- ketamine
- treatment
- pain disorder
- somatoform pain
- somatoform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 title 1
- 208000027520 Somatoform disease Diseases 0.000 title 1
- 229960003299 ketamine Drugs 0.000 title 1
- 208000027753 pain disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1518002.9A GB2543484A (en) | 2015-10-12 | 2015-10-12 | Ketamine for the treatment of somatoform pain disorder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1518002.9A GB2543484A (en) | 2015-10-12 | 2015-10-12 | Ketamine for the treatment of somatoform pain disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB201518002D0 true GB201518002D0 (en) | 2015-11-25 |
| GB2543484A GB2543484A (en) | 2017-04-26 |
Family
ID=55130908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1518002.9A Withdrawn GB2543484A (en) | 2015-10-12 | 2015-10-12 | Ketamine for the treatment of somatoform pain disorder |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2543484A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024240033A1 (en) * | 2023-05-19 | 2024-11-28 | 宜昌人福药业有限责任公司 | Ketamine liquid preparation and use thereof |
-
2015
- 2015-10-12 GB GB1518002.9A patent/GB2543484A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024240033A1 (en) * | 2023-05-19 | 2024-11-28 | 宜昌人福药业有限责任公司 | Ketamine liquid preparation and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2543484A (en) | 2017-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201609770TA (en) | Combination therapies for the treatment of cancer | |
| IL259996A (en) | Combinations for the treatment of cancer | |
| SMT202100115T1 (en) | Combinations of fgfr- and cmet-inhibitors for the treatment of cancer | |
| PL3964213T3 (en) | Treatment of conduct disorder | |
| GB201502137D0 (en) | Treatment | |
| GB201608885D0 (en) | Treatment | |
| IL257073A (en) | Combination therapies for treatment of cancer | |
| SMT202100245T1 (en) | Combination treatment of cancer | |
| GB201522243D0 (en) | Treatment | |
| ZA201705847B (en) | Treatment of pain | |
| GB201604658D0 (en) | Treatment for pain | |
| GB201508841D0 (en) | Treatment | |
| SG11201802292UA (en) | Composition for treating pain | |
| GB201522433D0 (en) | Cancer treatment | |
| GB201503008D0 (en) | Treatment | |
| GB201518002D0 (en) | Ketamine for the treatment of somatoform pain disorder | |
| GB201617107D0 (en) | Treatment | |
| GB201505205D0 (en) | Treatment for pain | |
| GB201504688D0 (en) | Treatment for pain | |
| GB201612260D0 (en) | Treatment | |
| GB201612193D0 (en) | Treatment | |
| GB201609683D0 (en) | Treatment | |
| GB201518349D0 (en) | Treatment | |
| GB201512723D0 (en) | Treatment of cancer | |
| GB201515739D0 (en) | Treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |